Insight on Pharmaceuticals and Healthcare in Italy

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Women's Health Market Strategies - Opportunities remain in this overlooked therapy area

This report aims to explore the opportunities and challenges in the women’s health sector. Market access is evaluated and includes analysis of drug sales, key players, regulatory trends, licensing deals, unmet needs, and marketing strategies.

Published By Datamonitor
12 Oct 2011 $5700
Buy
Report
Report

Treatment Algorithms: Type 2 Diabetes – Novel classes drive fragmentation of treatment choices in type 2 diabetes

Datamonitor reports average patient population and prescribing behavior by therapy line in the seven major markets, as well as analysis of therapy switching, patient share by drug class, and class use trends, based on a 199-physician survey.

Published By Datamonitor
27 Jul 2011 $7600
Buy
Report
Report

Treatment Algorithms: Schizophrenia – New antipsychotic launches underwhelm

Analysis of current treatment dynamics in schizophrenia. The report assesses patient diagnosis rates and uptake rates of approved treatments across the seven major markets using Datamonitor’s primary physician research of 140 psychiatrists.

Published By Datamonitor
15 May 2012 $7600
Buy
Report
Report

Treatment Algorithms: Rectal Cancer – Inclusion of chemoradiation can influence treatment and prescribing trends

This report provides analysis of current treatment dynamics of rectal cancer. Based on Datamonitor’s survey of 127 oncologists and cancer treaters the report assesses treatment type, prescribing influences, and patient numbers across disease stages.

Published By Datamonitor
26 Apr 2012 $7600
Buy
Report
Report

Treatment Algorithms: Psoriasis – Prescribing trends mirror guidelines

In this report, Datamonitor provides detailed treatment paths based on a survey of 125 dermatologists across the seven major markets, with analysis of patient potential, patient segmentation, prescribing patterns, and compliance among these patients.

Published By Datamonitor
21 Feb 2012 $7600
Buy
Report
Report

Treatment Algorithms: Prostate Cancer

Analysis of current treatment dynamics of prostate cancer. The report assesses uptake rates and order or treatment types across the seven major markets using Datamonitor’s primary physician research of 124 medical oncologists and urologists.

Published By Datamonitor
21 Dec 2011 $7600
Buy
Report
Report

Treatment Algorithms: Postherpetic Neuralgia – Lyrica forms the cornerstone of treatment for postherpetic neuralgia

Analysis of the treatment dynamics in postherpetic neuralgia (PHN). Contains analyses of presentation, diagnosis and treatment rates, and prescribing trends across the seven major markets using Datamonitor’s primary research of 131 physicians.

Published By Datamonitor
13 Nov 2012 $7600
Buy
Report
Report

Treatment Algorithms: Osteoporosis – A condition plagued by low diagnosis and treatment rates, low compliance, and the side effects of the key bisphosphonate class

Datamonitor outlines prescribing habits, patient segmentation, and treatment pathways for osteoporosis and provides insight into the most commonly used treatments across severities. Coverage: the US, Japan, France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
23 Aug 2012 $7600
Buy
Report
Report

Treatment Algorithms: Non-Small Cell Lung Cancer – Molecular profiling will increasingly guide the choice of therapy

This report provides analysis of current treatment dynamics of non-small cell lung cancer. Based on Datamonitor’s survey of 129 oncologists, the report assesses treatment type, prescribing influences, and patient numbers across disease stages.

Published By Datamonitor
09 Oct 2012 $7600
Buy
Report
Report

Treatment Algorithms: Multiple Sclerosis - Interferons remain the mainstay of multiple sclerosis treatment

Analysis of current treatment dynamics in multiple sclerosis. The report assesses the prescribing patterns, patient segmentation, and compliance rates across the seven major markets using Datamonitor’s primary physician research of 133 neurologists.

Published By Datamonitor
16 Mar 2012 $7600
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.